Sana Biotechnology SANA Institutional Ownership

Updated Oct 11, 2026

Sana Biotechnology, Inc. (NASDAQ:SANA) appeared in the 13F filings of 210 institutional investors for the quarter ended June 30, 2026.

• Together they owned 61.73% of the outstanding stock in Q2 2026, up from 59.30% a quarter earlier.
• Total holdings of SANA shares rose 12.53% from Q1 2026, and the holder count rose 37.25% from Q2 2025.
• Among the 210 holders of Sana Biotechnology, 103 added to their positions, 63 reduced their stakes and 44 left their positions unchanged.
• The aggregate institutional position in Sana Biotechnology was 184.76Mn shares at the end of Q2 2026, up 20.58Mn from the prior quarter and up 43.68Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Sana Biotechnology was FMR LLC with 37.43Mn shares, or 12.51% of shares outstanding.
• Holders that added the most shares of Sana Biotechnology in Q2 2026 were Bank of America Corp (+2.8Mn shares), BlackRock, Inc. (+2.43Mn shares), Marshall Wace, LLP (+2.27Mn shares), Vanguard Capital Management LLC (+940.7K shares) and State Street Corp (+665.05K shares).
• Among holders that kept a stake in Sana Biotechnology, the biggest sellers in Q2 2026 were Integral Health Asset Management, LLC (-1.2Mn shares), Millennium Management LLC (-937.53K shares), Goldman Sachs Group Inc (-813.18K shares), Two Sigma Investments, LP (-559.74K shares) and Citadel Advisors LLC (-407.91K shares).
• Per Business Quant data, the 10 largest holders of Sana Biotechnology at the end of Q2 2026 were FMR LLC (37.43Mn shares), Flagship Pioneering, LLC (25Mn shares), Ra Capital Management, L.P. (18.75Mn shares), BlackRock, Inc. (16.68Mn shares), State Street Corp (11.2Mn shares), Canada Pension Plan Investment Board (10.22Mn shares), Vanguard Capital Management LLC (8.38Mn shares), Bank of America Corp (5.75Mn shares), Geode Capital Management, LLC (4.68Mn shares) and Marex Group Ltd (3.99Mn shares).